Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Aurora Cannabis ( (TSE:ACB) ) is now available.
On June 18, 2025, Aurora Cannabis Inc. issued a statement denying rumors about an acquisition of MedLeaf Therapeutics, a New Zealand-based company. Aurora clarified that no discussions or agreements had taken place regarding such a transaction. Additionally, Aurora released its financial statements and management’s discussion for the fiscal year ending March 31, 2025, highlighting transparency in its operations. This announcement aims to correct misinformation and maintain investor confidence, emphasizing Aurora’s commitment to clear communication and strategic focus.
The most recent analyst rating on (TSE:ACB) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.
Spark’s Take on TSE:ACB Stock
According to Spark, TipRanks’ AI Analyst, TSE:ACB is a Neutral.
Aurora Cannabis scores a 50, reflecting a balance of significant financial difficulties and promising operational improvements. The positive earnings call and strategic corporate moves suggest potential growth, but the persistent financial challenges and high valuation limit the overall score. Continued focus on profitability and operational efficiency will be crucial.
To see Spark’s full report on TSE:ACB stock, click here.
More about Aurora Cannabis
Aurora Cannabis Inc. is a leading global medical cannabis company based in Edmonton, Alberta, Canada. It serves both medical and consumer markets across Canada, Europe, Australia, and New Zealand. The company offers a diverse portfolio of adult-use and medical cannabis brands, including Drift, San Rafael ’71, Daily Special, Tasty’s, Being, Greybeard, MedReleaf, CanniMed, Aurora, and Whistler Medical Marijuana Co., along with international brands such as Pedanios, Bidiol, IndiMed, and CraftPlant. Aurora also holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America.
Average Trading Volume: 447,684
Technical Sentiment Signal: Buy
Current Market Cap: C$457.2M
For a thorough assessment of ACB stock, go to TipRanks’ Stock Analysis page.